In a study of cancer-free men followed for a median of seven years, statin use was associated with a lower risk of developing prostate cancer. In the
study, this association was observed only when statins had been used for a relatively long duration or at a high dose, and it was more pronounced for aggressive prostate tumors.
Among 13,065 men in the study, 2,976 were diagnosed with prostate cancer over a follow-up of up to 22 years.
"More strictly designed clinical trial studies are needed to replicate this finding," said Kai Wang, first author, PhD, of Harvard University.